Align Technology kept at market outperform

JMP Securities analyst Anthony Ostrea maintained Align Technology, Inc. at market outperform, with a lowered price target of $10, from $11. Revenue will end up just slightly down this year at just less than $200 million (was $207 million in 2005) despite cuts to pricing and OrthoClear's attractive price point, according to the analyst. JMP reduced 2006 revenue expectations to $198.6 million, from $204.0 million. Shares of the Santa Clara, Calif.-based dental products company were down 26 cents, or 3.77%, at $6.63 on volume of 464,876 shares versus the three-month running average of 449,052 shares. (Nasdaq: ALGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.